Open AccessIn Reply
Author(s) -
Valachis Antonis,
Polyzos Nikolaos P.
Publication year - 2013
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2013-0235
Subject(s) - medicine , zoledronic acid , clinical trial , breast cancer , adjuvant , oncology , meta analysis , medical physics , cancer , intensive care medicine
Our meta‐analysis provides evidence that zoledronic acid in the adjuvant breast cancer setting may increase survival. Additional data from basic research and clinical trials in the future will help us interpret its role with more confidence.